輝瑞公司
US ˙ NYSE ˙ US7170811035

SecurityPFE / Pfizer Inc.
InstitutionQDYN - FlexShares Quality Dividend Dynamic Index Fund
Latest Disclosed Ownership10,416 shares
Latest Disclosed Value $ 405,078
QDYN - FlexShares Quality Dividend Dynamic Index Fund reports 0.57% decrease in ownership of PFE / Pfizer Inc.

On June 26, 2023 - QDYN - FlexShares Quality Dividend Dynamic Index Fund filed a NPORT-P form disclosing ownership of 10,416 shares of Pfizer Inc. (US:PFE) valued at $405,078 USD as of April 30, 2023. The entity filed a previous NPORT-P on March 24, 2023 disclosing 10,476 shares of Pfizer Inc.. This represents a change in shares of -0.57% during the quarter. The current value of the position is $267,587 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2023-06-26 2023-04-30 NP Pfizer EC US7170811035 10,416 -60 -0.57 405 -12.34 2.3136
2023-03-24 2023-01-31 NP Pfizer EC US7170811035 10,476 -847 -7.48 463 -12.33 2.6123
2022-12-27 2022-10-31 NP Pfizer EC US7170811035 11,323 -137 -1.20 527 -8.82 2.9181
2022-09-22 2022-07-31 NP Pfizer EC US7170811035 11,460 -881 -7.14 579 -4.46 3.0834
2022-06-28 2022-04-30 NP Pfizer EC US7170811035 12,341 119 0.97 606 -5.91 2.9292
2022-03-25 2022-01-31 NP Pfizer EC US7170811035 12,222 -231 -1.85 644 18.20 2.9049
2021-12-28 2021-10-31 NP Pfizer EC US7170811035 12,453 -1,351 -9.79 545 -7.80 2.4866
2021-09-27 2021-07-31 NP Pfizer EC US7170811035 13,804 10,787 357.54 591 408.62 2.7925
2021-06-25 2021-04-30 NP Pfizer EC US7170811035 3,017 -967 -24.27 117 -18.88 0.5736
2021-03-31 2021-01-31 NP Pfizer EC US7170811035 3,984 0 0.00 143 1.42 0.9271
2020-12-29 2020-10-31 NP Pfizer EC US7170811035 3,984 -657 -14.16 141 -20.79 1.0724
2020-09-24 2020-07-31 NP Pfizer EC US7170811035 4,641 -6,655 -58.91 179 -58.89 1.1470
2020-06-25 2020-04-30 NP Pfizer EC US7170811035 11,296 -18,029 -61.48 433 -60.35 2.7444
2020-03-27 2020-01-31 NP Pfizer EC US7170811035 29,325 -4,025 -12.07 1,092 -14.62 2.0270
2019-12-26 2019-10-31 NP Pfizer EC US7170811035 33,350 33,350 1,280 2.4464
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.